Evidence map›Paper›PMID 39349089›Full record

ArticleBone2024

Phlpp1 alters the murine chondrocyte phospho-proteome during endochondral bone formation.

Samantha R Weaver, Eduardo Peralta-Herrera, Haydee M Torres, Erik Jessen, Elizabeth W Bradley, Jennifer J Westendorf

Abstract read
In one paragraph

Article in Bone, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. PHLPP is neither a Phosphatase nor a Tumor Suppressor.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samantha R WeaverDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, United States of America.
Eduardo Peralta-HerreraDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, United States of America.
Haydee M TorresDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, United States of America.
Erik JessenDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, United States of America.
Elizabeth W BradleyDepartment of Orthopedics, School of Medicine, University of Minnesota, Minneapolis, MN, United States of America.
Jennifer J WestendorfDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, United States of America; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: westendorf.jennifer@mayo.edu.

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Lila J. Rutten · 1985 to 2026
$151.3M
Musculoskeletal Research Training ProgramT32AR056950 · NIAMS · MAYO CLINIC ROCHESTER · PI Jennifer J Westendorf · 2009 to 2026
$7.0M
Phlpp phosphatases in osteoarthritisR01AR078552 · NIAMS · MAYO CLINIC ROCHESTER · PI WESTENDORF, JENNIFER J · 2022 to 2025
$1.9M
Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in OsteoclastsR01AR072634 · NIAMS · UNIVERSITY OF MINNESOTA · PI BRADLEY, ELIZABETH W · 2017 to 2021
$1.7M
Phlpp protein phosphatases in cartilage development and diseaseR56AR068103 · NIAMS · MAYO CLINIC ROCHESTER · PI WESTENDORF, JENNIFER J · 2019 to 2019
$552k
Epigenetic Regulation of Phlpp1 in Cartilage Development and RegenerationK01AR065397 · NIAMS · MAYO CLINIC ROCHESTER · PI BRADLEY, ELIZABETH W · 2014 to 2018
$440k
Girk3 in bone biology and diseaseK99AR080745 · NIAMS · MAYO CLINIC ROCHESTER · PI WEAVER, SAMANTHA R · 2023 to 2024
$210k
NCI NIH HHS P30 CA015083NIAMS NIH HHS K01 AR065397NIAMS NIH HHS K99 AR080745NIAMS NIH HHS L70 AR083203NIAMS NIH HHS R01 AR072634NIAMS NIH HHS R01 AR078552NIAMS NIH HHS R56 AR068103NIAMS NIH HHS T32 AR056950
6 · The paper itself

Abstract

Appendicular skeletal growth and bone mass acquisition are controlled by a variety of growth factors, hormones, and mechanical forces in a dynamic process called endochondral ossification. In long bones, chondrocytes in the growth plate proliferate and undergo hypertrophy to drive bone lengthening and mineralization. Pleckstrin homology (PH) domain and leucine rich repeat phosphatase 1 and 2 (Phlpp1 and Phlpp2) are serine/threonine protein phosphatases that regulate cell proliferation, survival, and maturation via Akt, PKC, Raf1, S6k, and other intracellular signaling cascades. Germline deletion of Phlpp1 suppresses bone lengthening in growth plate chondrocytes. Here, we demonstrate that Phlpp2 does not regulate endochondral ossification, and we define the molecular differences between Phlpp1 and Phlpp2 in chondrocytes. Phlpp2

Indexed as

ChondrocytesOsteogenesisPhosphoprotein PhosphatasesProteomeAnimalsGrowth PlateMiceMice, KnockoutNuclear ProteinsPhosphoproteinsPhosphorylationNuclear ProteinsPHLPP1 protein, mousePHLPP2 protein, mousePhosphoprotein PhosphatasesPhosphoproteinsProteomeEndochondral ossificationMulti-omicsPhlpp2Phospho-proteomicsProteomicsTranscriptomics

Identifiers

PMID39349089
PMCPMC11549792

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.